Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

AstraZeneca - Small Deal With Amplimmune Provides No Quick Fixes
Seeking Alpha
Tuesday, August 27, 2013 - 9:09am
tags:
AstraZeneca, Amplimmune, M&A
Amarin Heading In The Right Direction Based On Script Data Trends
Seeking Alpha
Monday, August 26, 2013 - 6:38pm
tags:
Amarin, prescription data, Vascepa
Acura's abuse-deterrent pain drug fails mid-stage study goal
Reuters
Monday, August 26, 2013 - 6:37pm
tags:
abuse-resistant painkillers, Acura Pharmaceuticals, Aversion H&A
Pipeline Setback for Glaxo
Yahoo/Zacks
Monday, August 26, 2013 - 6:35pm
tags:
GSK, Vercirnon, Chron's Disease
Ampio Momentum Continues After Positive Initial Phase III Data
Seeking Alpha
Monday, August 26, 2013 - 6:35pm
tags:
Ampio Pharmaceuticals, Ampion
Will Amgen Stock Continue to Rise After Recent Acquisition?
Wall St. Cheat Sheet
Monday, August 26, 2013 - 6:34pm
tags:
Amgen, M&A, ONYX Pharmaceuticals
What Does The FDA's Breakthrough Designation Mean For Investors?
Seeking Alpha
Monday, August 26, 2013 - 1:28pm
tags:
FDA, breakthrough therapies, AbbVie, Alexion, Ariad Pharmaceuticals, Biomarin, Bristol-Myers Squibb, SynaGeva BioPharma, GSK, JNJ, Merck, Novartis, Pharmacyclics, Pfizer, Vertex Pharmaceuticals, daratumumab, ibrutinib, Kalydeco, lambrolizumab, palbociclib, LDK378, SD-101, obinutuzumab, serelaxin, asfotase alfa, bimagrumab, drisapersen, sebelipase alfa
For once, buyer sees bigger gains than seller in Amgen-Onyx deal
Marketwatch
Monday, August 26, 2013 - 12:02pm
tags:
ONYX Pharmaceuticals, M&A, Amgen
Entia Biosciences Completes Parkinson’s Disease Study
Yahoo/Accesswire
Monday, August 26, 2013 - 12:02pm
tags:
Entia Biosciences, Parkinson's Disease, ErgoD2
Making Sense Of The Latest Twists In The Twenty Year Agenus Saga
Seeking Alpha
Monday, August 26, 2013 - 12:00pm
tags:
Agenus
Alexza Pharmaceuticals: Stage Set For Adasuve
Seeking Alpha
Monday, August 26, 2013 - 10:46am
tags:
Alexza Pharmaceuticals, Adasuve, Teva Pharmaceuticals
Medtronic Is Changing Its Business. Will The System Let It?
Forbes
Monday, August 26, 2013 - 9:51am
tags:
Medtronic, devices, Cardiocom, patient monitors, M&A
Is There Any Substance To The Buyout Rumors Surrounding BioMarin And Catalyst?
Seeking Alpha
Monday, August 26, 2013 - 9:46am
tags:
M&A, Biomarin, Catalyst Pharmaceutical Partners
AstraZeneca forges $500M cancer-combo tech buyout for MedImmune
Fierce Biotech
Monday, August 26, 2013 - 9:34am
tags:
MedImmune, AstraZeneca, M&A
Ceptaris wins FDA OK for lymphoma gel, clears path to $250M Actelion buyout
Fierce Biotech
Monday, August 26, 2013 - 9:33am
tags:
Actelion, FDA, Ceptaris, Valchlor, cutaneous T-cell lymphoma
Study: More consumers turn to social media for health research
PharmaLive
Monday, August 26, 2013 - 9:30am
tags:
consumers, social media
Halt in Zilmax sales fuels demand for rival cattle feed product
Reuters
Monday, August 26, 2013 - 9:28am
tags:
Zilmax, Merck, Eli Lilly, animal health, Optaflexx
AstraZeneca to buy U.S. cancer firm for up to $500 mln
Reuters
Monday, August 26, 2013 - 9:26am
tags:
AstraZeneca, M&A, Amplimmune
Amgen to buy Onyx in deal worth $10.4 billion
Marketwatch
Monday, August 26, 2013 - 9:03am
tags:
Amgen, ONYX Pharmaceuticals, M&A
Sanofi Pasteur's Fluzone High-Dose Vaccine Significantly More Effective Than Standard Dose Fluzone Vaccine in Preventing Influenza in Adults 65 Years of Age and Older
Yahoo
Monday, August 26, 2013 - 8:08am
tags:
Sanofi Pasteur, Fluzone, vaccines, influenza

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.